1. |
Zheng Y, He M, Congdon N. The worldwide epidemic of diabetic retinopathy[J]. Indian J Ophthalmol, 2012, 60(5): 428-431. DOI: 10.4103/0301-4738.100542.
|
2. |
Liu Y, Yang J, Tao L, et al. Risk factors of diabetic retinopathy and sight-threatening diabetic retinopathy: a cross-sectional study of 13473 patients with type 2 diabetes mellitus in mainland China[J/OL]. BMJ Open, 2017, 7(9): e016280[2017-09-01]. https://pubmed.ncbi.nlm.nih.gov/28864696/. DOI: 10.1136/bmjopen-2017-016280.
|
3. |
Furuyama K, Kaneko K, Vargas PD. Heme as a magnificent molecule with multiple missions: heme determines its own fate and governs cellular homeostasis[J]. Tohoku J Exp Med, 2007, 213(1): 1-16. DOI: 10.1620/tjem.213.1.
|
4. |
Dunst J, Becker A, Lautenschläger C, et al. Anemia and elevated systemic levels of vascular endothelial growth factor (VEGF)[J]. Strahlenther Onkol, 2002, 178(8): 436-441. DOI: 10.1007/s00066-002-0925-8.
|
5. |
王敏, 汲宝兰, 班博, 等. 2型糖尿病患者血红蛋白水平与视网膜病变风险的相关研究[J]. 中华内分泌代谢杂志, 2019, 35(5): 387-390. DOI: 10.3760/cma.j.issn.1000-6699.2019.02.007.Wang M, Ji BL, Ban B, et al. Association between hemoglobin levels and diabetic retinopathy risk in type 2 diabetes mellitus[J]. Chin J Endocrinol Metab, 2019, 35(5): 387-390. DOI: 10.3760/cma.j.issn.1000-6699.2019.02.007.
|
6. |
Lee M, Han K, Lee J, et al. High hemoglobin levels are associated with decreased risk of diabetic retinopathy in Korean type 2 diabetes[J/OL]. Sci Rep, 2018, 8(1): 5538[2018-04-03]. https://pubmed.ncbi.nlm.nih.gov/29615813/. DOI: 10.1038/s41598-018-23905-2.
|
7. |
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版)[J]. 中华糖尿病杂志, 2018, 10(1): 4-67. DOI: 10.3760/cma.j.issn.1674-5809.2018.01.003.Diabetes Branch of Chinese Medical Association. Guidelines for the prevention and control of type 2 diabetes in China (2017 Edition)[J]. Chin J Diabetes Mellitus, 2018, 10(1): 4-67. DOI: 10.3760/cma.j.issn.1674-5809.2018.01.003.
|
8. |
Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie house classification. ETDRS report number 10[J]. Ophthalmology, 1991, 98(5 Suppl): 786-806.
|
9. |
Vujosevic S, Aldington SJ, Silva P, et al. Screening for diabetic retinopathy: new perspectives and challenges[J]. Lancet Diabetes Endocrinol, 2020, 8(4): 337-347. DOI: 10.1016/S2213-8587(19)30411-5.
|
10. |
Flaxel CJ, Adelman RA, Bailey ST, et al. Diabetic retinopathy preferred practice pattern®[J]. Ophthalmology, 2020, 127(1): P66-P145. DOI: 10.1016/j.ophtha.2019.09.025.
|
11. |
Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy[J]. Diabetes Care, 2012, 35(3): 556-564. DOI: 10.2337/dc11-1909.
|
12. |
李筱荣, 杨千惠. 美国眼科学会《糖尿病视网膜病变临床指南》解读[J]. 中华实验眼科杂志, 2020, 38(9): 795-798. DOI: 10.3760/cma.j.cn115989-20200518-00350.Li XR, Yang QH. Interpretation of diabetic retionpathy preferred practice pattern®[J]. Chin J Exp Ophthalmol, 2020, 38(9): 795-798. DOI: 10.3760/cma.j.cn115989-20200518-00350.
|
13. |
Hosseini MS, Rostami Z, Saadat A, et al. Anemia and microvascular complications in patients with type 2 diabetes mellitus[J/OL]. Nephrourol Mon, 2014, 6(4): e19976[2014-07-05]. https://pubmed.ncbi.nlm.nih.gov/25695026/. DOI: 10.5812/numonthly.19976.
|
14. |
Sepúlveda FJ, Pérez P, Medinilla MG, et al. Anemia as a factor related to the progression of proliferative diabetic retinopathy afer photocoagulation[J]. Diabetes Complications, 2012, 26(5): 454-457. DOI: 10.1016/j.jdiacomp.2012.04.013.
|
15. |
Chung JO, Park SY, Chung DJ, et al. Relationship between anemia, serum bilirubin concentrations and diabetic retinopathy in individuals with type 2 diabetes[J/OL]. Medicine (Baltimore), 2019, 98(43): e17693[2019-10-25]. https://pubmed.ncbi.nlm.nih.gov/31651899/. DOI: 10.1097/MD.0000000000017693.
|
16. |
Traveset A, Rubinat E, Ortega E, et al. Lower hemoglobin concentration is associated with retinal ischemia and the severity of diabetic retinopathy in type 2 diabetes[J/OL]. J Diabetes Res, 2016, 3674946[2016-04-20]. https://pubmed.ncbi.nlm.nih.gov/27200379/. DOI: 10.1155/2016/3674946.
|
17. |
Ajoy Mohan VK, Nithyanandam S, Idiculla J. Microalbuminuria and low hemoglobin as risk factors for the occurrence and increasing severity of diabetic retinopathy[J]. Indian J Ophthalmol, 2011, 59(3): 207-210. DOI: 10.4103/0301-4738.81029.
|
18. |
Davis MD, Fisher MR, Gagnon RE, et al. Risk factors for high risk proliferative diabetic retinopathy and severe visual loss: early treatment diabetic retinopathy study report 18[J]. Invest Ophthalmol Vis Sci, 1998, 39: 233-252.
|
19. |
Kajihara T, Uchino S, Suzuki M, et al. Human chorionic gonadotropin confers resistance to oxidative stress-induced apoptosis in decidualizing human endometrial stromal cells[J]. Fertil Steril, 2011, 95(4): 1302-1307. DOI: 10.1016/j.fertnstert.2010.05.048.
|
20. |
Rajabian F, Mohri M, Heidarpour M. Relationships between oxidative stress, haematology and iron profile in anaemic and non-anaemic calves[J/OL]. Vet Rec, 2017, 181(10): 265[2017-09-09]. https://pubmed.ncbi.nlm.nih.gov/28774940/. DOI: 10.1136/vr.104179.
|
21. |
DeNiro M, Al-Mohanna FA. Erythropoietin and anemia: biological markers that cannot be ignored in diabetic retinopathy[J]. Med Hypotheses, 2012, 78: 555-556. DOI: 10.1016/j.mehy.2012.01.026.
|
22. |
Bahar A, Kashi Z, Ahmadzadeh Amiri A, et al. Association between diabetic retinopathy and hemoglobin level[J]. Caspian J Intern Med, 2013, 4(4): 759-762.
|
23. |
Thomas MC. Anemia in diabetes: marker or mediator of microvascular disease?[J]. Nat Clin Pract Nephrol, 2007, 3: 20-30. DOI: 10.1038/ncpneph0378.
|